| Dr Kelley Pagliai Redbord, MD | |
|
243 Church St Nw, Suite 200-c, Vienna, VA 22180-4434 | |
| (703) 938-5700 | |
| (703) 938-4467 |
| Full Name | Dr Kelley Pagliai Redbord |
|---|---|
| Gender | Female |
| Speciality | Micrographic Dermatologic Surgery (mds) |
| Experience | 22 Years |
| Location | 243 Church St Nw, Vienna, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1134252455 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | 0101241641 (Virginia) | Primary |
| 207ND0101X | Dermatology - Mohs-micrographic Surgery | 0101241641 (Virginia) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Inova Fairfax Hospital | Falls church, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Advanced Dermatology Of Maryland Pc | 9931489804 | 37 |
| Advanced Dermatology Of Virginia Inc | 9436438538 | 21 |
| Dermatology And Dermatologic Surgery Group Of Northern Virginia Pllc | 5496823585 | 3 |
| Integrated Dermatology Of Fairfax Llc | 6103144753 | 5 |
News Archive
School districts across the U.S. struggle with the combination of two harsh realities: an increasing intensity of budget cuts for 2010-11, and complying with the federal Individuals with Disabilities Education Act which guarantees "free appropriate" education to all disabled students including the growing number of students with an Autism Spectrum Disorder.
A joint GA²LEN /EAACI report to be published in "Allergy" and available online on 8 February reviews new data on the treatment of allergies with older antihistamines compared with newer, second-generation H1-antihistamines. The research was funded by GA²LEN, an EU-funded Network of Excellence.
TESARO, Inc., an oncology-focused biopharmaceutical company, today announced that it has secured $60 million in start-up funding to acquire, develop and commercialize cancer therapeutics and supportive care products. Participants in a $20 million Series A financing included New Enterprise Associates (NEA) and TESARO management; additionally, NEA has reserved $40 million to support company growth.
The U.S. Food and Drug Administration's Center for Drug Evaluation and Research has funded a cooperative agreement to establish a Rare Disease Clinical Outcome Assessment Consortium.
› Verified 9 days ago
| Entity Name | Medical Faculty Associates, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417990581 PECOS PAC ID: 4082528898 Enrollment ID: O20031117000341 |
News Archive
School districts across the U.S. struggle with the combination of two harsh realities: an increasing intensity of budget cuts for 2010-11, and complying with the federal Individuals with Disabilities Education Act which guarantees "free appropriate" education to all disabled students including the growing number of students with an Autism Spectrum Disorder.
A joint GA²LEN /EAACI report to be published in "Allergy" and available online on 8 February reviews new data on the treatment of allergies with older antihistamines compared with newer, second-generation H1-antihistamines. The research was funded by GA²LEN, an EU-funded Network of Excellence.
TESARO, Inc., an oncology-focused biopharmaceutical company, today announced that it has secured $60 million in start-up funding to acquire, develop and commercialize cancer therapeutics and supportive care products. Participants in a $20 million Series A financing included New Enterprise Associates (NEA) and TESARO management; additionally, NEA has reserved $40 million to support company growth.
The U.S. Food and Drug Administration's Center for Drug Evaluation and Research has funded a cooperative agreement to establish a Rare Disease Clinical Outcome Assessment Consortium.
› Verified 9 days ago
| Entity Name | Dermatology & Dermatologic Surgery Group Of Northern Virginia Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1386810299 PECOS PAC ID: 5496823585 Enrollment ID: O20081002000187 |
News Archive
School districts across the U.S. struggle with the combination of two harsh realities: an increasing intensity of budget cuts for 2010-11, and complying with the federal Individuals with Disabilities Education Act which guarantees "free appropriate" education to all disabled students including the growing number of students with an Autism Spectrum Disorder.
A joint GA²LEN /EAACI report to be published in "Allergy" and available online on 8 February reviews new data on the treatment of allergies with older antihistamines compared with newer, second-generation H1-antihistamines. The research was funded by GA²LEN, an EU-funded Network of Excellence.
TESARO, Inc., an oncology-focused biopharmaceutical company, today announced that it has secured $60 million in start-up funding to acquire, develop and commercialize cancer therapeutics and supportive care products. Participants in a $20 million Series A financing included New Enterprise Associates (NEA) and TESARO management; additionally, NEA has reserved $40 million to support company growth.
The U.S. Food and Drug Administration's Center for Drug Evaluation and Research has funded a cooperative agreement to establish a Rare Disease Clinical Outcome Assessment Consortium.
› Verified 9 days ago
| Entity Name | Integrated Dermatology Of Fairfax Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861890303 PECOS PAC ID: 6103144753 Enrollment ID: O20150413000708 |
News Archive
School districts across the U.S. struggle with the combination of two harsh realities: an increasing intensity of budget cuts for 2010-11, and complying with the federal Individuals with Disabilities Education Act which guarantees "free appropriate" education to all disabled students including the growing number of students with an Autism Spectrum Disorder.
A joint GA²LEN /EAACI report to be published in "Allergy" and available online on 8 February reviews new data on the treatment of allergies with older antihistamines compared with newer, second-generation H1-antihistamines. The research was funded by GA²LEN, an EU-funded Network of Excellence.
TESARO, Inc., an oncology-focused biopharmaceutical company, today announced that it has secured $60 million in start-up funding to acquire, develop and commercialize cancer therapeutics and supportive care products. Participants in a $20 million Series A financing included New Enterprise Associates (NEA) and TESARO management; additionally, NEA has reserved $40 million to support company growth.
The U.S. Food and Drug Administration's Center for Drug Evaluation and Research has funded a cooperative agreement to establish a Rare Disease Clinical Outcome Assessment Consortium.
› Verified 9 days ago
| Entity Name | Advanced Dermatology Of Virginia Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801342639 PECOS PAC ID: 9436438538 Enrollment ID: O20161114000246 |
News Archive
School districts across the U.S. struggle with the combination of two harsh realities: an increasing intensity of budget cuts for 2010-11, and complying with the federal Individuals with Disabilities Education Act which guarantees "free appropriate" education to all disabled students including the growing number of students with an Autism Spectrum Disorder.
A joint GA²LEN /EAACI report to be published in "Allergy" and available online on 8 February reviews new data on the treatment of allergies with older antihistamines compared with newer, second-generation H1-antihistamines. The research was funded by GA²LEN, an EU-funded Network of Excellence.
TESARO, Inc., an oncology-focused biopharmaceutical company, today announced that it has secured $60 million in start-up funding to acquire, develop and commercialize cancer therapeutics and supportive care products. Participants in a $20 million Series A financing included New Enterprise Associates (NEA) and TESARO management; additionally, NEA has reserved $40 million to support company growth.
The U.S. Food and Drug Administration's Center for Drug Evaluation and Research has funded a cooperative agreement to establish a Rare Disease Clinical Outcome Assessment Consortium.
› Verified 9 days ago
| Entity Name | Advanced Dermatology Of Maryland Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760856413 PECOS PAC ID: 9931489804 Enrollment ID: O20161216000688 |
News Archive
School districts across the U.S. struggle with the combination of two harsh realities: an increasing intensity of budget cuts for 2010-11, and complying with the federal Individuals with Disabilities Education Act which guarantees "free appropriate" education to all disabled students including the growing number of students with an Autism Spectrum Disorder.
A joint GA²LEN /EAACI report to be published in "Allergy" and available online on 8 February reviews new data on the treatment of allergies with older antihistamines compared with newer, second-generation H1-antihistamines. The research was funded by GA²LEN, an EU-funded Network of Excellence.
TESARO, Inc., an oncology-focused biopharmaceutical company, today announced that it has secured $60 million in start-up funding to acquire, develop and commercialize cancer therapeutics and supportive care products. Participants in a $20 million Series A financing included New Enterprise Associates (NEA) and TESARO management; additionally, NEA has reserved $40 million to support company growth.
The U.S. Food and Drug Administration's Center for Drug Evaluation and Research has funded a cooperative agreement to establish a Rare Disease Clinical Outcome Assessment Consortium.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Kelley Pagliai Redbord, MD Po Box 79262, Baltimore, MD 21279-0262 Ph: (703) 938-5700 | Dr Kelley Pagliai Redbord, MD 243 Church St Nw, Suite 200-c, Vienna, VA 22180-4434 Ph: (703) 938-5700 |
News Archive
School districts across the U.S. struggle with the combination of two harsh realities: an increasing intensity of budget cuts for 2010-11, and complying with the federal Individuals with Disabilities Education Act which guarantees "free appropriate" education to all disabled students including the growing number of students with an Autism Spectrum Disorder.
A joint GA²LEN /EAACI report to be published in "Allergy" and available online on 8 February reviews new data on the treatment of allergies with older antihistamines compared with newer, second-generation H1-antihistamines. The research was funded by GA²LEN, an EU-funded Network of Excellence.
TESARO, Inc., an oncology-focused biopharmaceutical company, today announced that it has secured $60 million in start-up funding to acquire, develop and commercialize cancer therapeutics and supportive care products. Participants in a $20 million Series A financing included New Enterprise Associates (NEA) and TESARO management; additionally, NEA has reserved $40 million to support company growth.
The U.S. Food and Drug Administration's Center for Drug Evaluation and Research has funded a cooperative agreement to establish a Rare Disease Clinical Outcome Assessment Consortium.
› Verified 9 days ago
Dr. Marina Shuster Jungwirth, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2236c Gallows Rd, Fl 2, Vienna, VA 22182 Phone: 443-351-3376 | |
Dr. William Samuel Sawchuk, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8320 Old Courthouse Rd, Suite 303, Vienna, VA 22182 Phone: 703-532-7211 Fax: 703-534-2874 | |
Sylvia M Suarez, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 2236c Gallows Rd, Second Floor, Vienna, VA 22182 Phone: 703-827-7008 Fax: 703-827-7011 | |
Dr. Gayle Debra Masri-fridling, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 8320 Old Courthouse Rd, Suite 303, Vienna, VA 22182 Phone: 703-532-7211 Fax: 703-534-2874 | |
Dr. Naiem Tony Issa, M.D., PH.D. Dermatology Medicare: Medicare Enrolled Practice Location: 8301 Old Courthouse Rd, Vienna, VA 22182 Phone: 703-442-0300 Fax: 703-442-0337 | |
Dr. Saleh Rachidi, MD, PHD Dermatology Medicare: Medicare Enrolled Practice Location: 8100 Boone Blvd Ste 230, Vienna, VA 22182 Phone: 703-495-5555 |